Biggest News Aggregation in the World
📰 Nasdaq Pcvx News

Page 4 - Nasdaq Pcvx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Pcvx. Real-time updates on events, politics, business and more.

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $65.00 Average PT from Analysts

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have received an average rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued a report on the stock […]
Jim Wassil Cantor Fitzgerald Capital Research Global Investors Vaxcyte Inc Needham Company Blackrock Inc

Ginkgo Bioworks (NYSE:DNA) vs. Vaxcyte (NASDAQ:PCVX) Head to Head Comparison

Vaxcyte (NASDAQ:PCVX – Get Free Report) and Ginkgo Bioworks (NYSE:DNA – Get Free Report) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability. Analyst Recommendations This is a summary of recent […]
United States San Carlos Ginkgo Bioworks Holdings Inc Groupa Streptococcus Sutrovax Inc Vaxcyte Inc

Cantor Fitzgerald Equities Analysts Raise Earnings Estimates for Vaxcyte, Inc. (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2023 EPS estimates for shares of Vaxcyte in a report released on Wednesday, August 9th. Cantor Fitzgerald analyst L. Chen now expects that the company will post earnings per share of ($3.05) for the year, up from their prior estimate of ($3.15). […]
Cantor Fitzgerald Zurcher Kantonalbank Zurich Cantonalbank Vaxcyte Inc Groupa Streptococcus China Universal Asset Management Co First Horizon Advisors Inc

FY2023 EPS Estimates for Vaxcyte, Inc. Lifted by Analyst (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Cantor Fitzgerald increased their FY2023 EPS estimates for shares of Vaxcyte in a report released on Wednesday, August 9th. Cantor Fitzgerald analyst L. Chen now forecasts that the company will post earnings per share of ($3.05) for the year, up from their previous forecast of ($3.15). The consensus […]
Sectoral Asset Management Inc Vaxcyte Inc Cantor Fitzgerald Groupa Streptococcus Jennison Associates Needham Company
Source: wkrb13.com

Q3 2023 EPS Estimates for Vaxcyte, Inc. (NASDAQ:PCVX) Reduced by Analyst

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Leerink Partnrs cut their Q3 2023 EPS estimates for Vaxcyte in a research report issued on Sunday, August 13th. Leerink Partnrs analyst D. Risinger now anticipates that the company will earn ($0.73) per share for the quarter, down from their previous estimate of ($0.70). The consensus estimate for […]
Leerink Partnrs Capital Research Global Investors Groupa Streptococcus Vanguard Group Inc Vaxcyte Company Profile Blackrock Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Needham & Company LLC Reaffirms Buy Rating for Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a note issued to investors on Wednesday, Benzinga reports. They presently have a $58.00 price target on the stock. Needham & Company LLC’s target price would suggest a potential upside of 22.80% from the […]
United States Zurcher Kantonalbank Zurich Cantonalbank Needham Company Fund Management Co First Horizon Advisors Inc Vaxcyte Inc

Vaxcyte (NASDAQ:PCVX) Shares Gap Down to $47.61

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $47.61, but opened at $46.29. Vaxcyte shares last traded at $47.31, with a volume of 25,746 shares trading hands. Wall Street Analyst Weigh In A number of research analysts have weighed […]
United States Legato Capital Management Geode Capital Management Groupa Streptococcus Vaxcyte Company Profile Level Four Advisory Services
Source: wkrb13.com

Head to Head Contrast: Titan Pharmaceuticals (NASDAQ:TTNP) vs. Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Free Report) and Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability. Analyst Ratings This is a summary of recent recommendations for Vaxcyte […]
United States San Carlos South San Francisco Sutrovax Inc Groupa Streptococcus Titan Pharmaceuticals

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Acquired by Vivo Capital LLC

Vivo Capital LLC grew its position in Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) by 43.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 579,508 shares of the company’s stock after purchasing an additional 175,000 shares during the quarter. Vaxcyte makes up 3.2% of […]
United States Great West Life Assurance Co Vaxcyte Company Profile Exchange Commission Legato Capital Management Wells Fargo Company

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science